Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
Condition: Primary Immune Deficiency Intervention: Biological: GC5107 Sponsors: Green Cross Corporation; Atlantic Research Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2020 Category: Research Source Type: clinical trials